跳至主要内容
临床试验/NL-OMON51405
NL-OMON51405尚未招募不适用

The role of gutmicrobiota composition, epigenetics and autoimmunity in the development and treatment of vasculitis; the VASKIR biobank - GAVAS

Amsterdam UMC0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • All individuals with vasculitis visiting the outpatient clinic of Amsterdam
  • UMC region are potentially eligible if they are >18 years old
  • Vasculitis diagnosis is made by clinician. Vasculitis subtype will be
  • recorded along with the presence of auto-antibodies at time of diagnosis and
  • during remission (where applicable, e.g., in the case of AAV)

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Active infection at the time of inclusion (not to influence immune-cell
  • Unwillingness to donate feces, urine and/or blood
  • Inability to provide informed consent based on cognitive function, language
  • barrier or other reasons
  • Absence of large bowel (i.e., colostomy)

研究者

发起方
Amsterdam UMC

相似试验